Bruce N. Jacobs insider trades

Open-market stock purchases and sales by Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc, from SEC Form 4 filings since Aug 20, 2020.

Recent trades

DateStockTradeValue
Jun 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
May 18, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 4, 2026KYMR Kymera Therapeutics, IncSold$38.7K
Mar 4, 2026KYMR Kymera Therapeutics, IncSold$214K
Mar 4, 2026KYMR Kymera Therapeutics, IncSold$123K
Mar 4, 2026KYMR Kymera Therapeutics, IncSold$41.3K
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncSold$179K
Mar 2, 2026KYMR Kymera Therapeutics, IncSold$126K
Mar 2, 2026KYMR Kymera Therapeutics, IncSold$369K

Companies traded

  • KYMR Kymera Therapeutics, Inc: 33 sales, last Jun 2, 2026

Get free alerts when Bruce N. Jacobs files a new trade →